-
Lyme Disease Treatment Market to Witness Astonishing Growth by 2031: Sandoz AG, GlaxoSmithKline plc., and Hospira Inc.
19 Feb 2024 09:40 GMT
… development and boost return on investment (ROI). The region that is … Ltd.
◘ Sandoz AG
◘ GlaxoSmithKline plc.
◘ Hospira Inc.
Lyme Disease Treatment Market …
-
Andhra, Telangana luring more pharma investments
21 Aug 2023 09:06 GMT
… as to attract new investments in manufacturing and allied … are luring considerable pharma investments.
While Andhra Pradesh has … has been recognized as National Investment and Manufacturing Zone (NIMZ … number of pharma companies like Hospira, Mylan, Reddy’s Lab …
-
Generic Drugs Market USD 551330 million by 2028 | Top Regions, Development, Key Players, Market Dynamics | Sales, Price, Revenue, Gross Margin, Cost Analysis| Future Investment, Expansion Plan
04 Nov 2022 12:49 GMT
Pune, Nov. 04, 2022 (GLOBE NEWSWIRE) -- Generic Drugs market report shares valuable information about global development status, opportunities, and challenges in near future, as past data analyzed by industry experts which is helpful for you to take …
-
Pain Management Therapeutics Market Industry Landscape & Acknowledgment 2028 | Averitas Pharma, Cardinal Health, Hospira
21 Sep 2022 10:48 GMT
… Mapping of Market Parameters
• Attractive Investment Proposition in the Global Market … ., Forest Laboratories, Inc., GlaxoSmithKline plc, Hospira, Inc., Merck & Co., Inc …
-
Worldwide Epinephrine Autoinjector Industry to 2028 - Featuring Pfizer, Mylan, Sanofi and Hospira Among Others - ResearchAndMarkets.com
19 Sep 2022 15:42 GMT
… brings an insight into the investment areas that existing or new … Pharmaceuticals Ltd
Antares Pharma Inc.
Hospira Inc.
Impax Laboratories, Inc.
Bausch …
-
$880 Million Worldwide Filgrastim Biosimilars Industry to 2031 - Identify Growth Segments for Investment - ResearchAndMarkets.com
22 Apr 2022 10:00 GMT
…
Claris Life Sciences
Adello Biologics
Hospira (Pfizer)
Gennova Biopharmaceuticals
Teva Pharmaceuticals … analysis
Identify growth segments for investment
Outperform competitors using forecast data …
-
Global Infusion Pumps Market to 2029 - Featuring Baxter International, Medtronic and Hospira Among Others - ResearchAndMarkets.com
28 Mar 2022 09:57 GMT
… & Johnson Corporation
Medtronic Plc.
Hospira
Terumo Corporation
Smiths Medical
This … analysis tools such as attractive investment proposition and fractal map analysis … Future Prospects
3.5 Attractive Investment Proposition
3.1 Competitive Analysis …
-
Global Oncology Biosimilars Market (2022 to 2031) - Featuring Pfizer, Amgen and Hospira Among Others - ResearchAndMarkets.com
21 Mar 2022 15:31 GMT
… .
Sandoz International GmbH
BIOCAD
Amgen
Hospira
F.Hoffmann-La Roche
Baxter … analysis
Identify growth segments for investment
Outperform competitors using forecast data …
-
Cephalosporin Market Size Dominant with Business Challenges 2022 - Growth Drivers with Industry Innovations, New Investment Scenario, Research Scope and Share Forecast by 2025
15 Nov 2021 09:59 GMT
… Pharma ● Pernix Therapeutics ● Kyorin Pharmaceutical ● Hospira ● Astellas ● Orchid Pharma ● Shionogi ● … ● What are the attractive investment opportunities within the Cephalosporin market … with Industry Innovations, New Investment Scenario, Research Scope and …
-
Global Parenteral Nutrition Market (2021 to 2028) - Featuring Baxter International, Actavis and Hospira Among Others - ResearchAndMarkets.com
11 Nov 2021 15:09 GMT
… Melsungen AG
Fresenius Kabi AG
Hospira Inc.
Claris Lifesciences Limited
Sichuan … in 2020, owing to increasing investments in research and development by …